G3BP1 and renal cell adenocarcinoma: To further investigate the correlation of G3BP1 expression with RCC clinicopathologic features, a cohort comprising of 43 RCC patients were subjected to immunohistochemical (IHC) staining with an antibody specifically against G3BP1 (Fig. 1b).